EGR1 and Pelizeaus-Merzbacher spectrum disorder: These findings highlight the EGR1–ATF3 signaling axis as a critical driver of MuSC death and inflammaging in PMD, and suggest that its targeted inhibition may offer a promising therapeutic strategy for preventing or treating PMD.